Furthermore, some studies have found that TNF-α inhibition reduces SBP and left ventricular hypertrophy via AKT/eNOS pathway activation, thereby improving vascular function in hypertensive rats [44]. The gene discussed is TNF; the disease is left ventricular hypertrophy.